Promoting biosimilars up to health plans, manufacturers, doctors, Gottlieb says

21 March 2019 - As he wraps up his final weeks as commissioner of the FDA, Scott Gottlieb, MD, talked about ...

Read more →

AbbVie is sued for using Humira patent deals to block competition in the U.S.

20 March 2019 - In a novel step, a New York union accused AbbVie and seven other drug makers of ...

Read more →

Biosimilar groups offer proposals to help US better mirror EU successes

19 March 2019 - With 18 biosimilars approved in the US and just seven on the market, two biosimilars groups ...

Read more →

Biosimilar approval and adoption in the U.S. needs to be expedited

20 March 2019 - Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. ...

Read more →

Biosimilars Forum and Medicines for Europe call for changes to the US biosimilars market

19 March 2019 - The Biosimilars Forum and Medicines for Europe today released a joint white paper that discusses how Europe ...

Read more →

Statement from FDA Commissioner on FDA’s steps on naming of biological medicines to balance competition and safety for patients receiving these products

7 March 2019 - We’re at a critical point for the future of biosimilars in the U.S. Millions of American ...

Read more →

Samsung Bioepis gains approval to sell bigger size Ontruzant in Europe

5 March 2019 - Samsung Bioepis has gained approval to sell bigger-size Ontruzant in Europe, the company said Tuesday. ...

Read more →

Patient access to cost-effective treatments increased with launch of new biosimilar in Canada

28 February 2019 - First-ever pegfilgrastim biosimilar approved by Health Canada launches across the country. ...

Read more →

China approves first biosimilar of foreign drug, breaking Roche monopoly

27 February 2019 - China’s National Medical Products Administration announced Monday that it has approved the country's first biosimilar drug ...

Read more →

Canada finds "insufficient evidence" that Janssen blocked biosimilar competition

21 February 2019 - Despite the fact that the investigation confirmed many of the allegations against Janssen, the bureau concluded that, ...

Read more →

Diverging from FDA, Health Canada announces suffix-free biologic and biosimilar naming convention

18 February 2019 - Health Canada has announced that all biologics, including biosimilars, will be identified by their brand names and ...

Read more →

Pfizer receives European approval for Zirabev (bevacizumab), a biosimilar to Avastin

19 February 2019 - Pfizer today announced the European Commission has approved Zirabev for the treatment of metastatic carcinoma of ...

Read more →

Quebec appeals court orders province to restore full coverage of rheumatoid-arthritis drug Remicade

13 February 2019 - Quebec’s highest court has ordered the provincial government to restore full public coverage of Remicade, an ...

Read more →

What is a biosimilar, exactly?

5 February 2019 - They’re meant to save money for the health care system, carve into pharma’s profits, and finally ...

Read more →

Biosimilar uptake drivers

5 February 2019 - Information about Government initiatives to encourage the use of biosimilars is now available on the PBS website.  ...

Read more →